Beta-blockers (e.g., Metoprolol)
Treatment for Coronary Artery Disease
Typical Dosage: Metoprolol succinate ER: 25-200mg daily
Effectiveness
75%
Safety Score
70%
Clinical Trials
600
Participants
400K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Metoprolol succinate ER: 25-200mg daily
Time to Effect
immediate for heart rate/BP, months for cardiovascular protection
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
50(Treat 50 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
500(Treat 500 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$75
Side Effect Mgmt:$30
Total Annual:$145
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$12,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$1,450
Comparison vs No Treatment
Cost Difference
+$145/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
No dominance
Beta-blockers (e.g., Metoprolol) Outcomes
for Coronary Artery Disease
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+10%
Common Side Effects
Bradycardia
+10%
Fatigue
+15%
Dizziness
+8%
Sexual dysfunction
+7%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov